Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
D000609:Aminoacridines / Q000008:administration & dosage; D000677:Amsacrine; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D007399:Interphase; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000473:pathology; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology; D013936:Thymidine / Q000008:administration & dosage
D000609:Aminoacridines; D000677:Amsacrine; D003561:Cytarabine; D013936:Thymidine; D006918:Hydroxyurea